Skip to main content


Fig. 1 | Molecular Cancer

Fig. 1

From: LINC01133 as ceRNA inhibits gastric cancer progression by sponging miR-106a-3p to regulate APC expression and the Wnt/β-catenin pathway

Fig. 1

LINC01133 is downregulated in GC and negatively correlates with poor prognosis in GC patients. a. Relative expression of LINC01133 detected by qRT-PCR in 200 paired GC cancer tissues and matched normal tissues. Results are presented as Δ cycle threshold (ΔCt) in tumor tissues relative to normal tissues. b qRT-PCR analysis of the relative expression of LINC01133 in nine GC cell lines and the immortalized gastric normal mucosal cell line GES-1. c, d Relative expression of LINC01133 in GC with different TNM stage and different numbers of positive regional lymph nodes. e, f Kaplan-Meier plots of the OS and PFS of GC patients with high (n = 100) and low (n = 100) levels of LINC01133. Data are presented as the mean ± SD

Back to article page